A case of refractory idiopathic pure red cell aplasia responsive to fludarabine treatment [1]

British Journal of Haematology

Volumn 112, Issue 2, 2001, Pages 527-529

  Ahn, Jin Hee ^a   Lee, Kyoo Hyung ^a   Lee, Je Hwan ^a   Lee, Jung Shin ^a   Park, Chan Jeoung ^a   Chi, Hyun Sook ^a   Kim, Woo Kun ^a  

^a University of Ulsan College of Medicine   (South Korea)

Author keywords

Fludarabine; Pure red cell aplasia

Indexed keywords

FLUDARABINE;

ADULT; ANAMNESIS; CASE REPORT; DISEASE COURSE; DRUG RESPONSE; ERYTHROCYTE APLASIA; FEMALE; HUMAN; IDIOPATHIC DISEASE; LETTER; PRIORITY JOURNAL;

EID: 0035118083     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.2001.02540.x     Document Type: Letter

References (7)

1. Pure red cell aplasia in patients with chronic lymphocytic leukemia
2. Engraftment of allogeneic hematopoietic progenitor cells with purine analog-containing chemotherapy: Harnessing graft-versus-leukemia without myeloablative therapy
3. Cytopenia and fludarabine
4. Pure red-cell aplasia with fludarabine for chronic lymphocytic leukaemia
5. The prophylactic potential of fludarabine monophosphate in graft-versus-host disease after bone marrow transplantation in murine model
6. Refractory pure-red cell aplasia associated with B chronic lymphocytic leukemia successfully treated by fludarbaine
7. Refractory pure red cell aplasia associated with B-CLL: Successful treatment with a combination of fludarabine, cyclosporin A and erythropoietin